Original news and analysis on international IP policy
By Tove Iren S. Gerhardsen Intellectual property has become a major issue at this year’s World Health Assembly, with Brazil introducing a new draft resolution on public health, innovation and intellectual property, adding to various draft resolutions involving IP already…
By Tove Iren S. Gerhardsen Early in the 2007 World Health Assembly, the focus has moved to avian flu virus sample sharing for the development of treatments and access by both developed and developing countries. A drafting group started work…
By Tove Iren S. Gerhardsen Intellectual property rights issues could play a significant role in the annual World Health Assembly which begins next week. While not the most prominent topic for the assembly, IP is expected to arise in discussions…
By Tove Iren S. Gerhardsen The government of Brazil has issued a license that will allow the importation of cheaper versions of a patented HIV/AIDS drug after negotiations failed to bring about agreement on price reductions with Merck, the US…
By Tove Iren S. Gerhardsen A team from the independent investigative arm of the United States Congress visited Geneva last week, interviewing insiders from the private sector, non-governmental and international organisations including the World Health Organization (WHO) regarding how the…
By Tatum Anderson for Intellectual Property Watch A decision on whether the Indian patent law is compliant with World Trade Organisation intellectual property rules could be made sooner than expected, after a dramatic turn of events in the ongoing legal…
By Tove Iren S. Gerhardsen BRUSSELS – Whether research and development into new medicines for poor countries may best be secured through the strengthening of current partnerships or through entirely new schemes was the focus of an expert workshop held…
By Tove Iren S. Gerhardsen BRUSSELS – Sixteen member states of the World Health Organization have submitted their views on the way forward for an intergovernmental working group on public health and intellectual property, according to a senior WHO official.…
Par Tove Iren S. Gerhardsen Un représentant thaïlandais a déclaré que son Gouvernement recevait nettement plus d’appels depuis qu’il a émis des licences obligatoires pour importer et, à terme, produire des médicaments brevetés, contraignant les titulaires des brevets à baisser…
By Martin Vaughan for Intellectual Property Watch WASHINGTON, DC – Critics of Thailand’s decision to issue compulsory licenses for several patented drugs said the Thai government violated global trade rules, as they clashed with public health activists at a 16…